Comparing the efficacy of intralesional injection of verapamil combined with cryotherapy versus intralesional injection of triamcinolone combined with cryotherapy in keloids and hypertrophic scars

comparing the efficacy of intralesional injection of verapamil combined with cryotherapy versus intralesional injection of triamcinolone combined with cryotherapy in keloids and hypertrophic scars

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180327039151N1

Enrollment

Registered

2018-05-18

Start date

2016-11-21

Completion date

Unknown

Last updated

2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic scar. hypertrophic scar, verapamil, triamcinolone

Interventions

Intervention 1: Intervention group 1: triamcinolone, amp 40mg/ml, made in Exir company Iran, maximum 60mg in each session, intralesional injection, every 3 weeks, 8 sessions. Intervention 2: Intervent

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age 18-70 years old At least two lesions in each patient

Exclusion criteria

Exclusion criteria: Any infection around or near lesions Pregnant women History of previous intra lesional treatment Patient's lack of consent for having the lesion pictured

Design outcomes

Primary

Measure	Time frame
Score of keloid in Vancouver scar scale. Timepoint: Before intervention and 3, 6, 9, 12, 15, 18, 21, 24 weeks after intervention. Method of measurement: Vancouver scar scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Saki

Shiraz University of Medical Sciences

nasrinsa85@yahoo.com+98 71 3624 6921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026